Biotech
-
{
- All
- News
- Videos
-
Silicon Valley Startup Wants To Grow 'Headless Humans' To Replace Animal Testing
R3 Bio wants to grow human bodies without brains, which could replace lab animals in drug research and one day supply organs for transplantation.
-
Algae And Yeast For Skin? Biotech Skincare Could Compete With Korean Trends Any Day; Here's How
Biotech skincare could offer a competitive edge when targeted and personalised skincare is concerned. Here is what you need to know about biotech skincare and the risks that may be associated with it.
-
Algae And Yeast For Skin? Biotech Skincare Could Compete With Korean Trends Any Day; Here's How
Biotech skincare could offer a competitive edge when targeted and personalised skincare is concerned. Here is what you need to know about biotech skincare and the risks that may be associated with it.
-
Startup Builds Data Centres Powered By Human Brain Cells, Not Chips
Biotech startup Cortical Labs is working on two small data centers run by human brain cells.
-
Indian Woman Shares How She Bounced Back With A Job In Germany After Being Laid Off In US
Ananya Joshi revealed that she saw a LinkedIn posting for a biotech job in Germany just two hours before she was officially laid off from her role as a bioprocess scientist in the US.
-
AstraZeneca To Develop Gene-Editing Therapy Using Nobel Prize-Winning Tech
AstraZeneca would receive exclusive rights to develop and commercialise gene-editing therapies known as Crispr.
-
Here Are The Top Six Picks For October With Upto 39% Upside Potential Recommended By DRChoksey — Check List
Investment period for stock picks is six months from the date of the recommendations provided; and return calculated on six months highest price.
-
Biotech’s Latest Unicorn Uses AI To Mine Nature’s Medicine Chest
The big idea, Chief Executive Officer Viswa Colluru said, is to pick up where evolution left off.
-
12 Dividend Stocks: Patanjali Foods, Concord Biotech, Prestige, Asahi— Last Day To Buy Shares To Qualify
VST Tillers Tractors has announced a final dividend of Rs 20, followed by Concord Biotech with a final dividend of Rs 10.70.
-
Rossari Biotech Q1 Results — HPPC, New Capacities To Drive Earnings Growth, Says DRChoksey Maintaining Buy
DRChoksey value Rossari Biotech at a 23.0 times Jun’27 EPS, implying a target price of Rs 860
-
'Buy' EPL, 'Hold' SRF Among Others Lists ICICI Securities Ahead Of Specialty Chemicals Q1 Results
Specialty Chemicals' Ebitda on a low base, could grow 9.8% YoY/ dip 5.8% QoQ with SRF, Navin Fluorine, Gujarat Fluorochemicals, and Archean likely outperforming, adds ICICI Securities
-
Dividends And Stock Splits This Week — Bajaj Finance, Tata Power, Hindustan Zinc
Key names in focus include Bajaj Finance Ltd., Honeywell Automation India Ltd., Hindustan Zinc Ltd., and Tata Power Company Ltd., all of which have record dates coming up this week.
-
Researchers Challenge Claims of 'Leather-Like' T. rex Skin
VML, The Organoid Company, and Lab-Grown Leather Ltd claim to be producing luxury fashion accessories using lab-grown "T. rex leather" made from fossilized collagen. The product is marketed as a sustainable, cruelty-free alternative to traditional leather. However, palaeontologists strongly dispute the claim, citing the lack of dinosaur DNA and pre...
-
Specialty Chemicals Q4 Results Preview: ICICI Securities Expect Fewer EPS Downgrades
Ebitda, on a low base, should grow 33% YoY/23.4% QoQ with SRF, Navin Fluorine, Gujarat Fluorochemical, Archean and BlueJet likely outperforming, adds the brokerage.
-
Specialty Chemical Q4 Results Preview: Sustained Pricing Pressure To Weigh On Margin Recovery, Says DRChoksey
Based on the growth drivers, DRChoksey's top picks are UPL, supported by strong volume growth and gradual recovery in price, and Ami Organics, with strong growth in the Advanced Intermediates segment.
-
Silicon Valley Startup Wants To Grow 'Headless Humans' To Replace Animal Testing
R3 Bio wants to grow human bodies without brains, which could replace lab animals in drug research and one day supply organs for transplantation.
-
Algae And Yeast For Skin? Biotech Skincare Could Compete With Korean Trends Any Day; Here's How
Biotech skincare could offer a competitive edge when targeted and personalised skincare is concerned. Here is what you need to know about biotech skincare and the risks that may be associated with it.
-
Algae And Yeast For Skin? Biotech Skincare Could Compete With Korean Trends Any Day; Here's How
Biotech skincare could offer a competitive edge when targeted and personalised skincare is concerned. Here is what you need to know about biotech skincare and the risks that may be associated with it.
-
Startup Builds Data Centres Powered By Human Brain Cells, Not Chips
Biotech startup Cortical Labs is working on two small data centers run by human brain cells.
-
Indian Woman Shares How She Bounced Back With A Job In Germany After Being Laid Off In US
Ananya Joshi revealed that she saw a LinkedIn posting for a biotech job in Germany just two hours before she was officially laid off from her role as a bioprocess scientist in the US.
-
AstraZeneca To Develop Gene-Editing Therapy Using Nobel Prize-Winning Tech
AstraZeneca would receive exclusive rights to develop and commercialise gene-editing therapies known as Crispr.
-
Here Are The Top Six Picks For October With Upto 39% Upside Potential Recommended By DRChoksey — Check List
Investment period for stock picks is six months from the date of the recommendations provided; and return calculated on six months highest price.
-
Biotech’s Latest Unicorn Uses AI To Mine Nature’s Medicine Chest
The big idea, Chief Executive Officer Viswa Colluru said, is to pick up where evolution left off.
-
12 Dividend Stocks: Patanjali Foods, Concord Biotech, Prestige, Asahi— Last Day To Buy Shares To Qualify
VST Tillers Tractors has announced a final dividend of Rs 20, followed by Concord Biotech with a final dividend of Rs 10.70.
-
Rossari Biotech Q1 Results — HPPC, New Capacities To Drive Earnings Growth, Says DRChoksey Maintaining Buy
DRChoksey value Rossari Biotech at a 23.0 times Jun’27 EPS, implying a target price of Rs 860
-
'Buy' EPL, 'Hold' SRF Among Others Lists ICICI Securities Ahead Of Specialty Chemicals Q1 Results
Specialty Chemicals' Ebitda on a low base, could grow 9.8% YoY/ dip 5.8% QoQ with SRF, Navin Fluorine, Gujarat Fluorochemicals, and Archean likely outperforming, adds ICICI Securities
-
Dividends And Stock Splits This Week — Bajaj Finance, Tata Power, Hindustan Zinc
Key names in focus include Bajaj Finance Ltd., Honeywell Automation India Ltd., Hindustan Zinc Ltd., and Tata Power Company Ltd., all of which have record dates coming up this week.
-
Researchers Challenge Claims of 'Leather-Like' T. rex Skin
VML, The Organoid Company, and Lab-Grown Leather Ltd claim to be producing luxury fashion accessories using lab-grown "T. rex leather" made from fossilized collagen. The product is marketed as a sustainable, cruelty-free alternative to traditional leather. However, palaeontologists strongly dispute the claim, citing the lack of dinosaur DNA and pre...
-
Specialty Chemicals Q4 Results Preview: ICICI Securities Expect Fewer EPS Downgrades
Ebitda, on a low base, should grow 33% YoY/23.4% QoQ with SRF, Navin Fluorine, Gujarat Fluorochemical, Archean and BlueJet likely outperforming, adds the brokerage.
-
Specialty Chemical Q4 Results Preview: Sustained Pricing Pressure To Weigh On Margin Recovery, Says DRChoksey
Based on the growth drivers, DRChoksey's top picks are UPL, supported by strong volume growth and gradual recovery in price, and Ami Organics, with strong growth in the Advanced Intermediates segment.
